Organoids and 3D Cell Cultures: A Comprehensive Guide for Advancing Disease Modeling and Drug Discovery
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This extensive whitepaper provides an in-depth analysis of organoid and three-dimensional (3D) cell culture technologies, highlighting their role in revolutionizing biomedical research, disease modeling, and drug discovery. Unlike conventional 2D cell monolayers or animal models, organoids are self-organizing microtissues derived from pluripotent stem cells (PSCs) or adult stem cells (ASCs) that faithfully mimic the complex architecture, cellular heterogeneity, and functionality of native human organs. The guide outlines the historical milestones of organoid development and provides detailed experimental workflows for establishing various models, including intestinal, brain, hepatic, and patient-derived organoids (PDOs). PDOs are particularly valuable for personalized medicine, as they retain the genetic and phenotypic profiles of the original patient tumors, enabling highly accurate predictions of clinical drug responses. Despite their immense potential, traditional organoid cultures face significant limitations, such as batch-to-batch variability, the absence of immune and vascular networks, and the formation of necrotic cores due to diffusion limits. To overcome these hurdles, the article explores cutting-edge bioengineering solutions. The integration of microfluidic organ-on-a-chip platforms introduces dynamic fluid flow and mechanical stimulation, while 3D bioprinting allows for precise spatial construction of vascularized tissues. Additionally, artificial intelligence and machine learning are being deployed to automate high-content imaging analysis and optimize culture protocols, significantly enhancing experimental reproducibility and scalability. The document also examines the shifting regulatory landscape, notably the FDA Modernization Act 2.0, which removes the animal testing mandate for new drug candidates and paves the way for the regulatory acceptance of New Approach Methodologies (NAMs) like organoids. To meet these rigorous regulatory standards, researchers must rigorously assess model fidelity through functional maturity assays, single-cell transcriptomics, and spatial mapping. Supported by national standardization initiatives such as the NIH Standardized Organoid Modeling Center, organoid technology is transitioning from an artisanal laboratory technique into a robust, standardized platform. This convergence of biology, engineering, and data science promises to accelerate the development of precision therapeutics and reduce reliance on animal testing. Source: https://www.cellbiotek.com/posts/organoids-and-3d-cell-cultures-a-comprehensive-guide-for-advancing-disease-modeling-and-drug-discovery
Fields of Study & Subjects
3D Printing in Biomedical Research
Cancer Cells and Metastasis
Tissue Engineering and Regenerative Medicine
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 30 March 2026
- Language
- EN